CDH2 and prostate cancer: It has been reported that FGFR4 silencing in FGFR4-388Arg-expressing prostate cancer cell lines leads to the induction of E-cadherin expression and to decreased N-cadherin expression29, suggesting that FGFR4-388Arg may be related to EMT.